Deceptive argumentation against diagnostic microdosing of anticancer drugs

International Journal of Cancer

Volumn 135, Issue 7, 2014, Pages 1753-1754

  Theile, Dirk ^a   Mikus, Gerd ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; CISPLATIN;

ANTINEOPLASTIC ACTIVITY; CANCER RESISTANCE; CONCENTRATION RESPONSE; CYTOSTASIS; DIAGNOSTIC TEST; DNA ADDUCT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG EXPOSURE; DRUG MICRODOSE; DRUG RESEARCH; DRUG SENSITIVITY; HUMAN; IC 50; LETTER; PERIPHERAL BLOOD MONONUCLEAR CELL; PREDICTIVE VALUE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; DRUG DOSAGE CALCULATIONS; HUMANS; MASS SPECTROMETRY; METABOLIC CLEARANCE RATE; NEOPLASMS; TISSUE DISTRIBUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84904506329     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28806     Document Type: Letter

References (11)

1. Himmelstein KJ, Patton TF, Belt RJ, et al. Clinical kinetics on intact cisplatin and some related species. Clin Pharmacol Ther 1981; 29: 658-64.
2. Heil J, Reifferscheid G,. Detection of mammalian carcinogens with an immunological DNA synthesis-inhibition test. Carcinogenesis 1992; 13: 2389-94.
3. Gottesman MM, Fojo T, Bates SE,. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2000; 2: 48-58.
4. Theile D, Grebhardt S, Haefeli WE, et al. Involvement of drug transporters in the synergistic action of FOLFOX combination chemotherapy. Biochem Pharmacol 2009; 78: 1366-73.
5. Langer R, Specht K, Becker K, et al. Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. Clin Cancer Res 2005; 11: 7462-9.
6. van den Broek GB, Wildeman M, Rasch CR, et al. Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation. Int J Cancer 2009; 124: 2643-50.
7. Muller C, Laval F, Soues S, Birck C, Charcosset JY,. High cell density-dependent resistance and P-glycoprotein-mediated multidrug resistance in mitoxantrone-selected Chinese hamster cells. Biochem Pharmacol 1990; 43: 2091-102.
8. Diaz LA, Jr, Williams RT, Wu J, et al. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 2012; 486: 537-40.
9. Blagosklonny MV,. STI-571 must select for drug-resistant cells but no cell breathes fire out of its nostrils like a dragon. Leukemia 2002; 16: 570-2.
10. Eichbaum C, Cortese M, Blank A, et al. Concentration effect relationship of CYP3A inhibition by ritonavir in humans. Eur J Clin Pharmacol 2013; 69: 1795-800.
11. Bonetti A, Apostoli P, Zaninelli M, et al. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy. Clin Cancer Res 1996; 2: 1829-35.